Riociguat
Generic name: Pronounced as (rye'' oh sig' ue at)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 04/15/2017
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Drug interactions
IMPORTANT WARNING
Do not take riociguat if you are pregnant or plan to become pregnant. Riociguat may harm the fetus. If you are sexually active and able to become pregnant, you should not begin taking riociguat until a pregnancy test has shown that you are not pregnant. You must use reliable methods of birth control during treatment and for one month after stopping riociguat. Do not have unprotected sex. Talk to your doctor about birth control methods that are effective and will work for you. Call your doctor immediately if you miss a menstrual period or think you may be pregnant while you are taking riociguat.
If you are a parent or guardian of a female who had not yet reached puberty, check your child regularly to see if she is developing any signs of puberty (breast buds, pubic hair )and let her doctor know about any changes. Your child may reach puberty before having her first menstrual period.
Because of the risk of birth defects, riociguat is available only through a special restricted distribution program. A program called Adempas Risk Evaluation and Mitigation Strategies (REMS) Program has been set up for all female patients to make sure that they are tested for pregnancy every month during treatment and for 1 month after stopping riociguat.Female patients can get riociguat only if they are registered with Adempas REMS Program. During enrollment you will choose a certified specialty pharmacy that will ship your medication to you. Ask your doctor if you have any questions about how you will receive your medication.
Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with riociguat and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) to obtain the Medication Guide.
Talk to your doctor about the risks of taking riociguat.
Why is this medication prescribed?
Riociguat is used to treat pulmonary arterial hypertension (PAH; high blood pressure in the vessels that carry blood to the lungs). Riociguat is also used to treat chronic thromboembolic pulmonary hypertension (CTEPH; high blood pressure in the lung arteries caused by blood clots that narrow or block blood flow) in adults who cannot have surgery or for those treated with surgery who continue to have high lung blood pressure levels after surgery. Riociguat may improve the ability to exercise in people with PAH and CTEPH and may slow the worsening of symptoms in people with PAH. Riociguat is in a class of medications called soluble guanylate cyclase (sGC) stimulators. It works by relaxing the blood vessels in the lungs to allow blood to flow easily.
How should this medicine be used?
Riociguat comes as a tablet to take by mouth. It is usually taken with or without food 3 times a day. Take riociguat at around the same time(s) every day and space your doses about 6 to 8 hours apart. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take riociguat exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
If you cannot swallow the tablet whole, you can crush the tablet and mix the contents with a small amount of water or a soft food such as applesauce. Swallow the mixture right after you mix it.
Your doctor may start you on a low dose of riociguat and gradually increase your dose, not more than once every 2 weeks. Your doctor may decrease your dose if you experience side effects.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking riociguat,
-
tell your doctor and pharmacist if you are allergic to riociguat, any other medications, or any of the ingredients in riociguat tablets. Ask your pharmacist or check the Medication Guide for a list of the ingredients.
-
tell your doctor if you are taking or have recently taken a nitrate such as isosorbide dinitrate (Isordil, in BiDil), isosorbide mononitrate (Monoket), or nitroglycerin (Nitro-Dur, Nitromist, Nitrostat, Minitran, Rectiv, others),; phosphodiesterase inhibitors (PDE-5) such as avanafil (Stendra), sildenafil (Revatio, Viagra), tadalafil (Adcirca, Cialis), or vardenafil (Levitra, Staxyn); or if you are taking dipyridamole (Persantine, in Aggrenox), or theophylline (Theo-24, Theochron, Theolair, others). Your doctor will probably tell you not to take riociguat if you are taking this one or more of these medications. Do not take riociguat within 24 hours before or after taking sildenafil or within 24 hours before or 48 hours after taking tadalafil.
-
tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: certain antifungals such as itraconazole (Onmel, Sporanox) and ketoconazole (Extina, Nizoral, Xolegel); HIV protease inhibitors including ritonavir (Norvir, in Kaletra); certain medications for seizures such as carbamazepine (Epitol, Equetro, Tegretol, others), phenobarbital, and phenytoin (Dilantin, Phenytek); and medications for high blood pressure. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
-
if you are taking antacids containing aluminum hydroxide or magnesium hydroxide (Maalox, Mylanta, Tums, others), take them 1 hour before or 1 hour after taking riociguat.
-
tell your doctor what herbal products you are taking, especially St. John's wort.
-
tell your doctor if you have a pulmonary hypertension with idiopathic interstitial pneumonia (PH-IIP; lung disease). Your doctor will probably tell you not to take riociguat.
-
tell your doctor if you currently smoke or start or stop smoking during treatment. Also tell your doctor if you have recently had diarrhea, vomiting, or sweating a lot which may have caused dehydration (loss of a large amount of body fluids); any bleeding from your lung(s); if you have had a procedure to stop you from coughing up blood; if you have low blood pressure, pulmonary veno-occlusive disease (a blockage of veins in the lungs); or heart, kidney, or liver disease.
-
tell your doctor if you are breastfeeding. Do not breastfeed while you are taking riociguat.
-
you should know that riociguat can cause dizziness and lightheadedness. Do not drive a car or operate machinery until you know how this medication affects you.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
Skip the missed dose and continue your regular dosing schedule. If you miss taking riociguat for more than 3 days, call your doctor. Your doctor may want to restart your medication at a lower dose.
What side effects can this medication cause?
-
Riociguat may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
headache
-
constipation
-
heartburn
-
upset stomach
-
nausea
-
vomiting
-
diarrhea
-
swelling of your hands, legs, feet, and ankles
-
-
Some side effects can be serious. If you experience any of these symptoms or those in the SPECIAL PRECAUTIONS section, call your doctor immediately or get emergency medical treatment:
-
coughing up pink, frothy sputum or blood
-
fainting
-
chest pain
-
shortness of breath
-
-
Riociguat may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
What OTHER INFORMATION should I know?
Keep all appointments with your doctor. Your doctor will check your blood pressure regularly during your treatment with riociguat.
Do not let anyone else take your medication.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Repaglinide | Repaglinide The metabolism of Riociguat can be decreased when combined with Repaglinide. |
Montelukast | Montelukast The metabolism of Riociguat can be decreased when combined with Montelukast. |
Delavirdine | Delavirdine The serum concentration of Riociguat can be increased when it is combined with Delavirdine. |
Atorvastatin | Atorvastatin The metabolism of Riociguat can be decreased when combined with Atorvastatin. |
Aminophylline | Aminophylline Aminophylline may increase the hypotensive activities of Riociguat. |
Anagrelide | Anagrelide Anagrelide may increase the hypotensive activities of Riociguat. |
Calcium Carbonate | Calcium Carbonate Calcium carbonate can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Candesartan | Candesartan The metabolism of Riociguat can be decreased when combined with Candesartan. |
Cilostazol | Cilostazol Cilostazol may increase the hypotensive activities of Riociguat. |
Clopidogrel | Clopidogrel The metabolism of Riociguat can be decreased when combined with Clopidogrel. |
Fenofibrate | Fenofibrate The metabolism of Riociguat can be decreased when combined with Fenofibrate. |
Guanfacine | Guanfacine Guanfacine may decrease the antihypertensive activities of Riociguat. |
Magnesium Hydroxide | Magnesium Hydroxide Magnesium hydroxide can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Magnesium Oxide | Magnesium Oxide Magnesium oxide can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Methylergonovine | Methylergonovine Methylergometrine may decrease the antihypertensive activities of Riociguat. |
Naratriptan | Naratriptan Naratriptan may decrease the antihypertensive activities of Riociguat. |
Olsalazine | Olsalazine The therapeutic efficacy of Riociguat can be decreased when used in combination with Olsalazine. |
Paregoric | Paregoric The metabolism of Riociguat can be decreased when combined with Morphine. |
Penbutolol | Penbutolol Acebutolol may increase the hypotensive activities of Riociguat. |
Ranitidine | Ranitidine Ranitidine can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Reserpine | Reserpine Reserpine may increase the hypotensive activities of Riociguat. |
Rizatriptan | Rizatriptan Rizatriptan may decrease the antihypertensive activities of Riociguat. |
Sumatriptan | Sumatriptan Sumatriptan may decrease the antihypertensive activities of Riociguat. |
Tizanidine | Tizanidine The risk or severity of adverse effects can be increased when Tizanidine is combined with Riociguat. |
Zolmitriptan | Zolmitriptan Zolmitriptan may decrease the antihypertensive activities of Riociguat. |
Famotidine Injection | Famotidine Injection Famotidine can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Metronidazole Injection | Metronidazole Injection The metabolism of Riociguat can be decreased when combined with Metronidazole. |
Morphine Injection | Morphine Injection The metabolism of Riociguat can be decreased when combined with Morphine. |
Zidovudine Injection | Zidovudine Injection The metabolism of Riociguat can be decreased when combined with Zidovudine. |
Altretamine | Altretamine Amphetamine may increase the hypotensive activities of Riociguat. |
Cyclosporine | Cyclosporine Cyclosporine may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Torsemide | Torsemide The metabolism of Riociguat can be decreased when combined with Torasemide. |
Olanzapine | Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Riociguat. |
Eprosartan | Eprosartan Eprosartan may increase the hypotensive activities of Riociguat. |
Hydroxychloroquine | Hydroxychloroquine The metabolism of Riociguat can be decreased when combined with Hydroxychloroquine. |
Meloxicam | Meloxicam The therapeutic efficacy of Riociguat can be decreased when used in combination with Meloxicam. |
Pantoprazole | Pantoprazole Pantoprazole can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Telmisartan | Telmisartan Telmisartan may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Anakinra | Anakinra The metabolism of Riociguat can be increased when combined with Anakinra. |
Linezolid | Linezolid Linezolid may increase the hypotensive activities of Riociguat. |
Trimipramine | Trimipramine Trimipramine may decrease the antihypertensive activities of Riociguat. |
Etanercept Injection | Etanercept Injection The metabolism of Riociguat can be increased when combined with Etanercept. |
Perindopril | Perindopril Perindopril may increase the hypotensive activities of Riociguat. |
Choline Magnesium Trisalicylate | Choline Magnesium Trisalicylate The therapeutic efficacy of Riociguat can be decreased when used in combination with Choline magnesium trisalicylate. |
Dutasteride | Dutasteride Dutasteride may decrease the antihypertensive activities of Riociguat. |
Epinephrine Injection | Epinephrine Injection Epinephrine may decrease the antihypertensive activities of Riociguat. |
Eplerenone | Eplerenone Eplerenone may increase the hypotensive activities of Riociguat. |
Olmesartan | Olmesartan Olmesartan may increase the hypotensive activities of Riociguat. |
Adalimumab Injection | Adalimumab Injection The metabolism of Riociguat can be increased when combined with Adalimumab. |
Aripiprazole | Aripiprazole The risk or severity of hypotension can be increased when Aripiprazole is combined with Riociguat. |
Atomoxetine | Atomoxetine Atomoxetine may decrease the antihypertensive activities of Riociguat. |
Dexmethylphenidate | Dexmethylphenidate Dexmethylphenidate may decrease the antihypertensive activities of Riociguat. |
Atazanavir | Atazanavir The serum concentration of Riociguat can be increased when it is combined with Atazanavir. |
Almotriptan | Almotriptan The metabolism of Riociguat can be decreased when combined with Almotriptan. |
Eletriptan | Eletriptan Eletriptan may decrease the antihypertensive activities of Riociguat. |
Vardenafil | Vardenafil Vardenafil may increase the hypotensive activities of Riociguat. |
Alfuzosin | Alfuzosin Alfuzosin may increase the hypotensive activities of Riociguat. |
Tegaserod | Tegaserod The metabolism of Riociguat can be decreased when combined with Tegaserod. |
Tadalafil | Tadalafil The risk or severity of hypotension can be increased when Tadalafil is combined with Riociguat. |
Frovatriptan | Frovatriptan Frovatriptan may decrease the antihypertensive activities of Riociguat. |
Progesterone | Progesterone Progesterone may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Apomorphine Injection | Apomorphine Injection The metabolism of Riociguat can be decreased when combined with Apomorphine. |
Infliximab Injection | Infliximab Injection The metabolism of Riociguat can be increased when combined with Infliximab. |
Protriptyline | Protriptyline Protriptyline may decrease the antihypertensive activities of Riociguat. |
Rifaximin | Rifaximin The metabolism of Riociguat can be increased when combined with Rifaximin. |
Duloxetine | Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Riociguat is combined with Duloxetine. |
Bosentan | Bosentan Bosentan may increase the hypotensive activities of Riociguat. |
Erlotinib | Erlotinib The metabolism of Riociguat can be decreased when combined with Erlotinib. |
Eszopiclone | Eszopiclone The metabolism of Riociguat can be decreased when combined with Eszopiclone. |
Solifenacin | Solifenacin Solifenacin may decrease the antihypertensive activities of Riociguat. |
Voriconazole | Voriconazole The serum concentration of Riociguat can be increased when it is combined with Voriconazole. |
Dextroamphetamine | Dextroamphetamine Amphetamine may increase the hypotensive activities of Riociguat. |
Isocarboxazid | Isocarboxazid Isocarboxazid may increase the hypotensive activities of Riociguat. |
Fentanyl | Fentanyl Fentanyl may decrease the antihypertensive activities of Riociguat. |
Deferasirox | Deferasirox The metabolism of Riociguat can be decreased when combined with Deferasirox. |
Phenylephrine | Phenylephrine Phenylephrine may decrease the antihypertensive activities of Riociguat. |
Tipranavir | Tipranavir The serum concentration of Tipranavir can be increased when it is combined with Riociguat. |
Abatacept Injection | Abatacept Injection The metabolism of Riociguat can be increased when combined with Abatacept. |
Rasagiline | Rasagiline Rasagiline may increase the hypotensive activities of Riociguat. |
Imatinib | Imatinib Imatinib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Sitagliptin | Sitagliptin The metabolism of Riociguat can be decreased when combined with Sitagliptin. |
Gefitinib | Gefitinib Gefitinib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Albuterol | Albuterol Salbutamol may decrease the antihypertensive activities of Riociguat. |
Paliperidone | Paliperidone Paliperidone may decrease the antihypertensive activities of Riociguat. |
Clofarabine Injection | Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Riociguat. |
Posaconazole | Posaconazole The serum concentration of Riociguat can be increased when it is combined with Posaconazole. |
Rituximab Injection | Rituximab Injection Riociguat may increase the hypotensive activities of Rituximab. |
Aliskiren | Aliskiren Riociguat may increase the hypotensive activities of Aliskiren. |
Darunavir | Darunavir The serum concentration of Darunavir can be increased when it is combined with Riociguat. |
Lisdexamfetamine | Lisdexamfetamine Lisdexamfetamine may decrease the antihypertensive activities of Riociguat. |
Nabilone | Nabilone The metabolism of Riociguat can be decreased when combined with Nabilone. |
Sorafenib | Sorafenib The metabolism of Riociguat can be decreased when combined with Sorafenib. |
Sunitinib | Sunitinib Sunitinib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Dronabinol | Dronabinol Dronabinol may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Lapatinib | Lapatinib The metabolism of Riociguat can be decreased when combined with Lapatinib. |
Dasatinib | Dasatinib Dasatinib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Nilotinib | Nilotinib The serum concentration of Riociguat can be increased when it is combined with Nilotinib. |
Bexarotene | Bexarotene The metabolism of Riociguat can be decreased when combined with Bexarotene. |
Desmopressin | Desmopressin Desmopressin may decrease the antihypertensive activities of Riociguat. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Riociguat. |
Nebivolol | Nebivolol Nebivolol may increase the hypotensive activities of Riociguat. |
Tretinoin | Tretinoin The metabolism of Riociguat can be decreased when combined with Tretinoin. |
Certolizumab Injection | Certolizumab Injection The metabolism of Riociguat can be increased when combined with Certolizumab pegol. |
Eltrombopag | Eltrombopag Eltrombopag may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Dexlansoprazole | Dexlansoprazole Dexlansoprazole can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Betaxolol | Betaxolol Betaxolol may increase the hypotensive activities of Riociguat. |
Iloperidone | Iloperidone Iloperidone may decrease the antihypertensive activities of Riociguat. |
Dronedarone | Dronedarone Dronedarone may decrease the antihypertensive activities of Riociguat. |
Golimumab Injection | Golimumab Injection The metabolism of Riociguat can be increased when combined with Golimumab. |
Pazopanib | Pazopanib The metabolism of Riociguat can be decreased when combined with Pazopanib. |
Asenapine | Asenapine Asenapine may decrease the antihypertensive activities of Riociguat. |
Pitavastatin | Pitavastatin The metabolism of Riociguat can be decreased when combined with Pitavastatin. |
Tocilizumab Injection | Tocilizumab Injection The metabolism of Riociguat can be increased when combined with Tocilizumab. |
Cabazitaxel Injection | Cabazitaxel Injection The metabolism of Riociguat can be decreased when combined with Cabazitaxel. |
Lurasidone | Lurasidone Lurasidone may decrease the antihypertensive activities of Riociguat. |
Vilazodone | Vilazodone Vilazodone may decrease the antihypertensive activities of Riociguat. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Riociguat. |
Terbutaline Injection | Terbutaline Injection Terbutaline may decrease the antihypertensive activities of Riociguat. |
Azilsartan | Azilsartan The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Riociguat. |
Roflumilast | Roflumilast Roflumilast may increase the hypotensive activities of Riociguat. |
Rilpivirine | Rilpivirine Rilpivirine may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Telaprevir | Telaprevir Glecaprevir may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Cyclophosphamide Injection | Cyclophosphamide Injection The metabolism of Riociguat can be increased when combined with Cyclophosphamide. |
Abiraterone | Abiraterone The metabolism of Riociguat can be decreased when combined with Abiraterone. |
Vandetanib | Vandetanib Vandetanib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Vemurafenib | Vemurafenib Vemurafenib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Vismodegib | Vismodegib Vismodegib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Cabergoline | Cabergoline Cabergoline may decrease the antihypertensive activities of Riociguat. |
Naloxone Injection | Naloxone Injection The serum concentration of Riociguat can be increased when it is combined with Naloxone. |
Ambrisentan | Ambrisentan Ambrisentan may increase the hypotensive activities of Riociguat. |
Iloprost | Iloprost Iloprost may increase the hypotensive activities of Riociguat. |
Enzalutamide | Enzalutamide The metabolism of Riociguat can be decreased when combined with Enzalutamide. |
Mirabegron | Mirabegron Mirabegron may decrease the antihypertensive activities of Riociguat. |
Regorafenib | Regorafenib Regorafenib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Bosutinib | Bosutinib The metabolism of Riociguat can be decreased when combined with Bosutinib. |
Teriflunomide | Teriflunomide Teriflunomide may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Cabozantinib (thyroid cancer) | Cabozantinib (thyroid cancer) The metabolism of Riociguat can be decreased when combined with Cabozantinib. |
Ponatinib | Ponatinib The metabolism of Riociguat can be decreased when combined with Ponatinib. |
Apixaban | Apixaban The metabolism of Riociguat can be decreased when combined with Apixaban. |
Canagliflozin | Canagliflozin The risk or severity of adverse effects can be increased when Canagliflozin is combined with Riociguat. |
Methazolamide | Methazolamide The risk or severity of adverse effects can be increased when Methazolamide is combined with Riociguat. |
Dabrafenib | Dabrafenib The metabolism of Riociguat can be decreased when combined with Dabrafenib. |
Trametinib | Trametinib The metabolism of Riociguat can be decreased when combined with Trametinib. |
Afatinib | Afatinib Afatinib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Levomilnacipran | Levomilnacipran The metabolism of Riociguat can be decreased when combined with Levomilnacipran. |
Vortioxetine | Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Riociguat. |
Avanafil | Avanafil Avanafil may increase the hypotensive activities of Riociguat. |
Ketorolac Injection | Ketorolac Injection The therapeutic efficacy of Riociguat can be decreased when used in combination with Ketorolac. |
Obinutuzumab Injection | Obinutuzumab Injection Riociguat may increase the hypotensive activities of Obinutuzumab. |
Simeprevir | Simeprevir Simeprevir may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Dapagliflozin | Dapagliflozin The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Riociguat. |
Apremilast | Apremilast Apremilast may increase the hypotensive activities of Riociguat. |
Droxidopa | Droxidopa Droxidopa may decrease the antihypertensive activities of Riociguat. |
Siltuximab Injection | Siltuximab Injection The metabolism of Riociguat can be increased when combined with Siltuximab. |
Empagliflozin | Empagliflozin The risk or severity of adverse effects can be increased when Empagliflozin is combined with Riociguat. |
Olaparib | Olaparib Olaparib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Methamphetamine | Methamphetamine Metamfetamine may decrease the antihypertensive activities of Riociguat. |
Secukinumab Injection | Secukinumab Injection The metabolism of Riociguat can be increased when combined with Secukinumab. |
Risperidone Injection | Risperidone Injection Riociguat may increase the hypotensive activities of Risperidone. |
Palbociclib | Palbociclib Palbociclib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Lenvatinib | Lenvatinib The metabolism of Riociguat can be decreased when combined with Lenvatinib. |
Dinutuximab Injection | Dinutuximab Injection The risk or severity of adverse effects can be increased when Dinutuximab is combined with Riociguat. |
Haloperidol Injection | Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Riociguat. |
Amiloride | Amiloride The risk or severity of adverse effects can be increased when Amiloride is combined with Riociguat. |
Macitentan | Macitentan Riociguat may increase the hypotensive activities of Macitentan. |
Flibanserin | Flibanserin Flibanserin may decrease the antihypertensive activities of Riociguat. |
Rolapitant | Rolapitant Rolapitant may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Daclatasvir | Daclatasvir Daclatasvir may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Brexpiprazole | Brexpiprazole Brexpiprazole may decrease the antihypertensive activities of Riociguat. |
Ziprasidone Injection | Ziprasidone Injection Ziprasidone may increase the antihypertensive activities of Riociguat. |
Cariprazine | Cariprazine Cariprazine may decrease the antihypertensive activities of Riociguat. |
Alectinib | Alectinib Alectinib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Rifapentine | Rifapentine The metabolism of Riociguat can be increased when combined with Rifapentine. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Riociguat. |
Dexamethasone Injection | Dexamethasone Injection The metabolism of Riociguat can be increased when combined with Dexamethasone. |
Venetoclax | Venetoclax Venetoclax may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Cobicistat | Cobicistat The serum concentration of Riociguat can be increased when it is combined with Cobicistat. |
Midodrine | Midodrine Midodrine may decrease the antihypertensive activities of Riociguat. |
Selexipag | Selexipag The metabolism of Selexipag can be decreased when combined with Riociguat. |
Furosemide Injection | Furosemide Injection Furosemide may increase the hypotensive activities of Riociguat. |
Rucaparib | Rucaparib Rucaparib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Ribociclib | Ribociclib The serum concentration of Riociguat can be increased when it is combined with Ribociclib. |
Brigatinib | Brigatinib The metabolism of Riociguat can be decreased when combined with Brigatinib. |
Doxepin (Insomnia) | Doxepin (Insomnia) Doxepin may decrease the antihypertensive activities of Riociguat. |
Safinamide | Safinamide Safinamide may increase the hypotensive activities of Riociguat. |
Midostaurin | Midostaurin The serum concentration of Riociguat can be increased when it is combined with Midostaurin. |
Enasidenib | Enasidenib The metabolism of Riociguat can be decreased when combined with Enasidenib. |
Abemaciclib | Abemaciclib Abemaciclib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Letermovir | Letermovir Letermovir may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Buprenorphine Injection | Buprenorphine Injection Buprenorphine may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Apalutamide | Apalutamide The metabolism of Apalutamide can be decreased when combined with Riociguat. |
Fostamatinib | Fostamatinib Fostamatinib may increase the hypotensive activities of Riociguat. |
Avatrombopag | Avatrombopag Avatrombopag may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Baricitinib | Baricitinib Baricitinib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Sodium Zirconium Cyclosilicate | Sodium Zirconium Cyclosilicate Sodium zirconium cyclosilicate can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Lofexidine | Lofexidine Lofexidine may decrease the antihypertensive activities of Riociguat. |
Elagolix | Elagolix The metabolism of Elagolix can be decreased when combined with Riociguat. |
Cannabidiol | Cannabidiol Cannabidiol may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Dacomitinib | Dacomitinib Dacomitinib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Stiripentol | Stiripentol The serum concentration of Riociguat can be increased when it is combined with Stiripentol. |
Gilteritinib | Gilteritinib Gilteritinib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Glasdegib | Glasdegib Glasdegib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Lorlatinib | Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Riociguat. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Riociguat. |
Rifamycin | Rifamycin The metabolism of Riociguat can be decreased when combined with Rifamycin. |
Emapalumab-lzsg Injection | Emapalumab-lzsg Injection The metabolism of Riociguat can be increased when combined with Emapalumab. |
Siponimod | Siponimod Siponimod may decrease the antihypertensive activities of Riociguat. |
Esomeprazole Injection | Esomeprazole Injection Esomeprazole can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Alpelisib | Alpelisib The metabolism of Riociguat can be decreased when combined with Alpelisib. |
Solriamfetol | Solriamfetol Solriamfetol may decrease the antihypertensive activities of Riociguat. |
Darolutamide | Darolutamide The serum concentration of Riociguat can be increased when it is combined with Darolutamide. |
Triclabendazole | Triclabendazole The metabolism of Riociguat can be decreased when combined with Triclabendazole. |
Istradefylline | Istradefylline The metabolism of Istradefylline can be decreased when combined with Riociguat. |
Pitolisant | Pitolisant The serum concentration of Riociguat can be decreased when it is combined with Pitolisant. |
Fedratinib | Fedratinib Fedratinib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Phenytoin Injection | Phenytoin Injection The metabolism of Riociguat can be decreased when combined with Phenytoin. |
Fosphenytoin Injection | Fosphenytoin Injection The metabolism of Riociguat can be decreased when combined with Fosphenytoin. |
Lasmiditan | Lasmiditan The serum concentration of Riociguat can be increased when it is combined with Lasmiditan. |
Cenobamate | Cenobamate The serum concentration of Riociguat can be decreased when it is combined with Cenobamate. |
Ozanimod | Ozanimod The metabolism of Ozanimod can be decreased when combined with Riociguat. |
Selumetinib | Selumetinib The metabolism of Selumetinib can be decreased when combined with Riociguat. |
Tucatinib | Tucatinib The metabolism of Tucatinib can be decreased when combined with Riociguat. |
Ripretinib | Ripretinib Ripretinib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Selpercatinib | Selpercatinib The serum concentration of Riociguat can be increased when it is combined with Selpercatinib. |
Capmatinib | Capmatinib The serum concentration of Riociguat can be increased when it is combined with Capmatinib. |
Fostemsavir | Fostemsavir Fostemsavir may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Pralsetinib | Pralsetinib Pralsetinib may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Opicapone | Opicapone The metabolism of Riociguat can be decreased when combined with Opicapone. |
Satralizumab-mwge Injection | Satralizumab-mwge Injection The serum concentration of Riociguat can be decreased when it is combined with Satralizumab. |
Naxitamab-gqgk Injection | Naxitamab-gqgk Injection Naxitamab may decrease the antihypertensive activities of Riociguat. |
Theophylline | Theophylline Theophylline may increase the hypotensive activities of Riociguat. |
Fenoprofen | Fenoprofen The therapeutic efficacy of Riociguat can be decreased when used in combination with Fenoprofen. |
Indomethacin | Indomethacin The therapeutic efficacy of Riociguat can be decreased when used in combination with Indomethacin. |
Mefenamic Acid | Mefenamic Acid The therapeutic efficacy of Riociguat can be decreased when used in combination with Mefenamic acid. |
Naproxen | Naproxen The therapeutic efficacy of Riociguat can be decreased when used in combination with Naproxen. |
Tolmetin | Tolmetin The therapeutic efficacy of Riociguat can be decreased when used in combination with Tolmetin. |
Sulindac | Sulindac The therapeutic efficacy of Riociguat can be decreased when used in combination with Sulindac. |
Trazodone | Trazodone Trazodone may decrease the antihypertensive activities of Riociguat. |
Sodium Bicarbonate | Sodium Bicarbonate Sodium bicarbonate can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Phenobarbital | Phenobarbital The metabolism of Riociguat can be increased when combined with Phenobarbital. |
Primidone | Primidone Primidone may increase the hypotensive activities of Riociguat. |
Diethylpropion | Diethylpropion Diethylpropion may decrease the antihypertensive activities of Riociguat. |
Chlorpromazine | Chlorpromazine Chlorpromazine may decrease the antihypertensive activities of Riociguat. |
Phenoxybenzamine | Phenoxybenzamine Phenoxybenzamine may decrease the antihypertensive activities of Riociguat. |
Bromocriptine | Bromocriptine Bromocriptine may decrease the antihypertensive activities of Riociguat. |
Metaproterenol | Metaproterenol Orciprenaline may decrease the antihypertensive activities of Riociguat. |
Tranylcypromine | Tranylcypromine Tranylcypromine may increase the hypotensive activities of Riociguat. |
Phenelzine | Phenelzine Phenelzine may increase the hypotensive activities of Riociguat. |
Procarbazine | Procarbazine Procarbazine may increase the hypotensive activities of Riociguat. |
Ergoloid Mesylates | Ergoloid Mesylates Ergoloid mesylate may decrease the antihypertensive activities of Riociguat. |
Thioridazine | Thioridazine Thioridazine may decrease the antihypertensive activities of Riociguat. |
Trifluoperazine | Trifluoperazine Trifluoperazine may decrease the antihypertensive activities of Riociguat. |
Dapsone | Dapsone The metabolism of Riociguat can be decreased when combined with Dapsone. |
Sulfadiazine | Sulfadiazine The metabolism of Riociguat can be decreased when combined with Sulfadiazine. |
Methadone | Methadone The metabolism of Riociguat can be decreased when combined with Methadone. |
Oxybutynin | Oxybutynin The metabolism of Riociguat can be decreased when combined with Oxybutynin. |
Ibuprofen | Ibuprofen The therapeutic efficacy of Riociguat can be decreased when used in combination with Ibuprofen. |
Phentermine | Phentermine Phentermine may decrease the antihypertensive activities of Riociguat. |
Methylphenidate | Methylphenidate Methylphenidate may decrease the antihypertensive activities of Riociguat. |
Amoxapine | Amoxapine Amoxapine may decrease the antihypertensive activities of Riociguat. |
Sulfasalazine | Sulfasalazine Sulfasalazine may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Hydrocortisone | Hydrocortisone The metabolism of Riociguat can be increased when combined with Hydrocortisone. |
Methyldopa | Methyldopa Methyldopa may increase the hypotensive activities of Riociguat. |
Clonidine | Clonidine The risk or severity of hypotension can be increased when Clonidine is combined with Riociguat. |
Prazosin | Prazosin The risk or severity of hypotension can be increased when Prazosin is combined with Riociguat. |
Hydralazine | Hydralazine Hydralazine may increase the hypotensive activities of Riociguat. |
Cimetidine | Cimetidine Cimetidine can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Warfarin | Warfarin The metabolism of Riociguat can be decreased when combined with Warfarin. |
Loperamide | Loperamide The serum concentration of Riociguat can be increased when it is combined with Loperamide. |
Meclofenamate | Meclofenamate The therapeutic efficacy of Riociguat can be decreased when used in combination with Meclofenamic acid. |
Griseofulvin | Griseofulvin The metabolism of Riociguat can be increased when combined with Griseofulvin. |
Chloroquine | Chloroquine The metabolism of Riociguat can be decreased when combined with Chloroquine. |
Quinine | Quinine The metabolism of Riociguat can be decreased when combined with Quinine. |
Triamterene | Triamterene The risk or severity of adverse effects can be increased when Triamterene is combined with Riociguat. |
Sulfinpyrazone | Sulfinpyrazone The metabolism of Riociguat can be decreased when combined with Sulfinpyrazone. |
Chlorothiazide | Chlorothiazide The therapeutic efficacy of Riociguat can be increased when used in combination with Chlorothiazide. |
Chlorthalidone | Chlorthalidone Chlorthalidone may increase the hypotensive activities of Riociguat. |
Metolazone | Metolazone Metolazone may increase the hypotensive activities of Riociguat. |
Isosorbide | Isosorbide Isosorbide may increase the hypotensive activities of Riociguat. |
Secobarbital | Secobarbital The metabolism of Riociguat can be increased when combined with Secobarbital. |
Desipramine | Desipramine Desipramine may decrease the antihypertensive activities of Riociguat. |
Amitriptyline | Amitriptyline The metabolism of Riociguat can be decreased when combined with Amitriptyline. |
Imipramine | Imipramine Imipramine may decrease the antihypertensive activities of Riociguat. |
Probenecid | Probenecid The metabolism of Riociguat can be increased when combined with Probenecid. |
Quinidine | Quinidine Quinidine may decrease the antihypertensive activities of Riociguat. |
Rifampin | Rifampin The metabolism of Riociguat can be increased when combined with Rifampicin. |
Valproic Acid | Valproic Acid The metabolism of Riociguat can be decreased when combined with Valproic acid. |
Tamoxifen | Tamoxifen The metabolism of Riociguat can be decreased when combined with Tamoxifen. |
Butabarbital | Butabarbital Butabarbital may increase the hypotensive activities of Riociguat. |
Levothyroxine | Levothyroxine The metabolism of Riociguat can be decreased when combined with Levothyroxine. |
Methimazole | Methimazole The serum concentration of Riociguat can be increased when it is combined with Methimazole. |
Tolbutamide | Tolbutamide The metabolism of Riociguat can be decreased when combined with Tolbutamide. |
Baclofen | Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Riociguat. |
Methyclothiazide | Methyclothiazide The therapeutic efficacy of Riociguat can be increased when used in combination with Methyclothiazide. |
Hydrochlorothiazide | Hydrochlorothiazide The therapeutic efficacy of Riociguat can be increased when used in combination with Hydrochlorothiazide. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) Propranolol may increase the hypotensive activities of Riociguat. |
Minoxidil | Minoxidil Minoxidil may increase the hypotensive activities of Riociguat. |
Pseudoephedrine | Pseudoephedrine Pseudoephedrine may decrease the antihypertensive activities of Riociguat. |
Nortriptyline | Nortriptyline Nortriptyline may decrease the antihypertensive activities of Riociguat. |
Spironolactone | Spironolactone The metabolism of Riociguat can be decreased when combined with Spironolactone. |
Amphotericin B Injection | Amphotericin B Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Riociguat. |
Mercaptopurine | Mercaptopurine Mercaptopurine may increase the hypotensive activities of Riociguat. |
Nadolol | Nadolol Nadolol may increase the hypotensive activities of Riociguat. |
Papaverine | Papaverine The risk or severity of adverse effects can be increased when Papaverine is combined with Riociguat. |
Fluorouracil Injection | Fluorouracil Injection The metabolism of Riociguat can be decreased when combined with Fluorouracil. |
Colchicine | Colchicine The metabolism of Riociguat can be decreased when combined with Colchicine. |
Ketoconazole | Ketoconazole The serum concentration of Riociguat can be increased when it is combined with Ketoconazole. |
Captopril | Captopril Captopril may increase the hypotensive activities of Riociguat. |
Dipyridamole | Dipyridamole Dipyridamole may increase the hypotensive activities of Riociguat. |
Isoxsuprine | Isoxsuprine Isoxsuprine may decrease the antihypertensive activities of Riociguat. |
Ethacrynic Acid | Ethacrynic Acid The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Riociguat. |
Metoprolol | Metoprolol Metoprolol may increase the hypotensive activities of Riociguat. |
Aspirin | Aspirin Acetylsalicylic acid may decrease the antihypertensive activities of Riociguat. |
Salsalate | Salsalate The therapeutic efficacy of Riociguat can be decreased when used in combination with Salsalate. |
Trimethoprim | Trimethoprim The metabolism of Riociguat can be decreased when combined with Trimethoprim. |
Diltiazem | Diltiazem The metabolism of Riociguat can be decreased when combined with Diltiazem. |
Nifedipine | Nifedipine The metabolism of Riociguat can be decreased when combined with Nifedipine. |
Timolol | Timolol Timolol may increase the hypotensive activities of Riociguat. |
Verapamil | Verapamil The metabolism of Riociguat can be decreased when combined with Verapamil. |
Atenolol | Atenolol Atenolol may increase the hypotensive activities of Riociguat. |
Pindolol | Pindolol Pindolol may increase the hypotensive activities of Riociguat. |
Diflunisal | Diflunisal The therapeutic efficacy of Riociguat can be decreased when used in combination with Diflunisal. |
Piroxicam | Piroxicam The therapeutic efficacy of Riociguat can be decreased when used in combination with Piroxicam. |
Bumetanide | Bumetanide The risk or severity of adverse effects can be increased when Bumetanide is combined with Riociguat. |
Indapamide | Indapamide The therapeutic efficacy of Riociguat can be increased when used in combination with Indapamide. |
Pentoxifylline | Pentoxifylline Pentoxifylline may increase the hypotensive activities of Riociguat. |
Labetalol | Labetalol Labetalol may increase the hypotensive activities of Riociguat. |
Gemfibrozil | Gemfibrozil The metabolism of Riociguat can be decreased when combined with Gemfibrozil. |
Guanabenz | Guanabenz Riociguat may decrease the antihypertensive activities of Guanabenz. |
Ketoprofen | Ketoprofen The therapeutic efficacy of Riociguat can be decreased when used in combination with Ketoprofen. |
Enalapril | Enalapril Enalapril may increase the hypotensive activities of Riociguat. |
Flurbiprofen | Flurbiprofen The therapeutic efficacy of Riociguat can be decreased when used in combination with Flurbiprofen. |
Amiodarone | Amiodarone The metabolism of Amiodarone can be decreased when combined with Riociguat. |
Buspirone | Buspirone Buspirone may decrease the antihypertensive activities of Riociguat. |
Lovastatin | Lovastatin The metabolism of Riociguat can be decreased when combined with Lovastatin. |
Mesalamine | Mesalamine The therapeutic efficacy of Riociguat can be decreased when used in combination with Mesalazine. |
Diclofenac | Diclofenac The therapeutic efficacy of Riociguat can be decreased when used in combination with Diclofenac. |
Nimodipine | Nimodipine Nimodipine may increase the hypotensive activities of Riociguat. |
Clozapine | Clozapine Clozapine may decrease the antihypertensive activities of Riociguat. |
Clarithromycin | Clarithromycin The serum concentration of Riociguat can be increased when it is combined with Clarithromycin. |
Benazepril | Benazepril Benazepril may increase the hypotensive activities of Riociguat. |
Etodolac | Etodolac The therapeutic efficacy of Riociguat can be decreased when used in combination with Etodolac. |
Felodipine | Felodipine The metabolism of Riociguat can be decreased when combined with Felodipine. |
Fosinopril | Fosinopril Fosinopril may increase the hypotensive activities of Riociguat. |
Nabumetone | Nabumetone The therapeutic efficacy of Riociguat can be decreased when used in combination with Nabumetone. |
Pravastatin | Pravastatin Pravastatin may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Quinapril | Quinapril Quinapril may increase the hypotensive activities of Riociguat. |
Ramipril | Ramipril Ramipril may increase the hypotensive activities of Riociguat. |
Simvastatin | Simvastatin The metabolism of Riociguat can be decreased when combined with Simvastatin. |
Amlodipine | Amlodipine Amlodipine may increase the hypotensive activities of Riociguat. |
Itraconazole | Itraconazole The serum concentration of Riociguat can be increased when it is combined with Itraconazole. |
Lisinopril | Lisinopril Lisinopril may increase the hypotensive activities of Riociguat. |
Oxaprozin | Oxaprozin The therapeutic efficacy of Riociguat can be decreased when used in combination with Oxaprozin. |
Rifabutin | Rifabutin The metabolism of Riociguat can be increased when combined with Rifabutin. |
Sotalol | Sotalol The risk or severity of adverse effects can be increased when Sotalol is combined with Riociguat. |
Bisoprolol | Bisoprolol Bisoprolol may increase the hypotensive activities of Riociguat. |
Doxazosin | Doxazosin Doxazosin may increase the hypotensive activities of Riociguat. |
Terazosin | Terazosin Terazosin may increase the hypotensive activities of Riociguat. |
Isradipine | Isradipine Isradipine may increase the hypotensive activities of Riociguat. |
Omeprazole | Omeprazole Omeprazole can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Cisapride | Cisapride The metabolism of Riociguat can be decreased when combined with Cisapride. |
Fluvastatin | Fluvastatin The metabolism of Riociguat can be decreased when combined with Fluvastatin. |
Venlafaxine | Venlafaxine Venlafaxine may increase the excretion rate of Riociguat which could result in a lower serum level and potentially a reduction in efficacy. |
Nizatidine | Nizatidine Nizatidine can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Nefazodone | Nefazodone The serum concentration of Riociguat can be increased when it is combined with Nefazodone. |
Losartan | Losartan The metabolism of Riociguat can be decreased when combined with Losartan. |
Moexipril | Moexipril Moexipril may increase the hypotensive activities of Riociguat. |
Lansoprazole | Lansoprazole Lansoprazole can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Ifosfamide Injection | Ifosfamide Injection The metabolism of Riociguat can be increased when combined with Ifosfamide. |
Nicardipine | Nicardipine The metabolism of Riociguat can be decreased when combined with Nicardipine. |
Ticlopidine | Ticlopidine The metabolism of Riociguat can be decreased when combined with Ticlopidine. |
Saquinavir | Saquinavir The serum concentration of Saquinavir can be increased when it is combined with Riociguat. |
Nisoldipine | Nisoldipine Nisoldipine may increase the hypotensive activities of Riociguat. |
Amifostine Injection | Amifostine Injection Riociguat may increase the hypotensive activities of Amifostine. |
Anastrozole | Anastrozole The metabolism of Riociguat can be decreased when combined with Anastrozole. |
Ritonavir | Ritonavir The serum concentration of Riociguat can be increased when it is combined with Ritonavir. |
Clomipramine | Clomipramine Clomipramine may decrease the antihypertensive activities of Riociguat. |
Zafirlukast | Zafirlukast The metabolism of Riociguat can be decreased when combined with Zafirlukast. |
Mirtazapine | Mirtazapine Mirtazapine may decrease the antihypertensive activities of Riociguat. |
Trandolapril | Trandolapril Trandolapril may increase the hypotensive activities of Riociguat. |
Valsartan | Valsartan Valsartan may increase the hypotensive activities of Riociguat. |
Pramipexole | Pramipexole The risk or severity of adverse effects can be increased when Pramipexole is combined with Riociguat. |
Nelfinavir | Nelfinavir Nelfinavir may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Loratadine | Loratadine The metabolism of Riociguat can be decreased when combined with Loratadine. |
Carvedilol | Carvedilol Carvedilol may increase the hypotensive activities of Riociguat. |
Nilutamide | Nilutamide The metabolism of Riociguat can be decreased when combined with Nilutamide. |
Selegiline | Selegiline Selegiline may increase the hypotensive activities of Riociguat. |
Propafenone | Propafenone Propafenone may decrease the antihypertensive activities of Riociguat. |
Raloxifene | Raloxifene The metabolism of Riociguat can be decreased when combined with Raloxifene. |
Irbesartan | Irbesartan The metabolism of Riociguat can be decreased when combined with Irbesartan. |
Tamsulosin | Tamsulosin The risk or severity of adverse effects can be increased when Tamsulosin is combined with Riociguat. |
Ropinirole | Ropinirole The risk or severity of adverse effects can be increased when Ropinirole is combined with Riociguat. |
Finasteride | Finasteride Finasteride may decrease the antihypertensive activities of Riociguat. |
Quetiapine | Quetiapine Quetiapine may increase the hypotensive activities of Riociguat. |
Tolcapone | Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Riociguat. |
Efavirenz | Efavirenz The serum concentration of Riociguat can be increased when it is combined with Efavirenz. |
Sildenafil | Sildenafil The risk or severity of hypotension can be increased when Sildenafil is combined with Riociguat. |
Pioglitazone | Pioglitazone The metabolism of Riociguat can be decreased when combined with Pioglitazone. |
Celecoxib | Celecoxib The therapeutic efficacy of Riociguat can be decreased when used in combination with Celecoxib. |
Rosiglitazone | Rosiglitazone The metabolism of Riociguat can be decreased when combined with Rosiglitazone. |
Thalidomide | Thalidomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Riociguat. |
Aluminum Hydroxide | Aluminum Hydroxide Aluminum hydroxide can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Balsalazide | Balsalazide The therapeutic efficacy of Riociguat can be decreased when used in combination with Balsalazide. |
Rabeprazole | Rabeprazole Rabeprazole can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Terbinafine | Terbinafine The metabolism of Riociguat can be decreased when combined with Terbinafine. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists